Wed, Sep 09, 2026 - Page 12
6504 indexed SquawkNews stories from this UTC day. Showing 1321-1440.
L
Corton Capital launches Class ETF Units for Corton Theta Alpha Fund
Corton Capital Inc. announced the public launch of Class ETF Units for the actively managed Corton Theta Alpha Fund ETF, expanding its actively-managed funds suite.
EQUITY | Sep 09, 2026, 06:19 PM UTC
L
UBS cites Aritzia long-term EPS growth despite comp focus
UBS says Aritzia’s long-term growth trajectory is being overshadowed as investors focus on comp sales normalization after the company laps last year’s mobile app launch.
EARNINGS | Sep 09, 2026, 06:19 PM UTC
M
DBS Group sued for S$1.298 billion in alleged 1MDB-linked claim
DBS Group said DBS Bank is being sued for estimated S$1.298 billion ($1.03 billion) in damages tied to the 1MDB scandal. Claimants include liquidators of four companies.
REGULATION | Sep 09, 2026, 06:18 PM UTC
L
UBS cuts Pacific Biosciences price target to $1.35 from $1.50
UBS cut its price target for Pacific Biosciences to $1.35 per share from $1.50, according to Benzinga ratings actions.
EQUITY | Sep 09, 2026, 06:18 PM UTC
L
Apple event over
Apple event over
EQUITY | Sep 09, 2026, 06:17 PM UTC
L
iPhone Duo Pre-Orders Begin 16th October, Available From 23rd October
iPhone Duo Pre-Orders Begin 16th October, Available From 23rd October
EQUITY | Sep 09, 2026, 06:17 PM UTC
L
Apple iPhone Duo starts at $1,999; storage 256GB to 2TB
iPhone Duo pricing starts at $1,999, with storage ranging from 256GB to 2TB.
EQUITY | Sep 09, 2026, 06:16 PM UTC
L
Apple iPhone Duo pricing starts at $1,999 for 256GB
Apple’s iPhone Duo starts at $1,999 for 256 gigabytes.
EQUITY | Sep 09, 2026, 06:16 PM UTC
L
Apple says iPhone Duo starts at $1,999
Apple says iPhone Duo starts at $1,999. Storage runs from 256 GB to 2 TB.
EQUITY | Sep 09, 2026, 06:16 PM UTC
L
ROIV: Mosliciguat's breakthrough data and brepocitinib's strong launch drive broad pipeline momentum
Mosliciguat delivered record efficacy in pulmonary hypertension, prompting broad indication expansion and rapid phase III initiation. Brepocitinib's DM launch is progressing steadily, with strong physician interest and s
EQUITY | Sep 09, 2026, 06:15 PM UTC
L
iPhone Duo starts at $1999
iPhone Duo starts at $1999
EQUITY | Sep 09, 2026, 06:15 PM UTC
L
UBS keeps Myriad Genetics at neutral; price target cut
UBS maintains a neutral view on Myriad Genetics and cuts its price target to $3.60 per share from $6.00, according to Benzinga ratings actions.
EQUITY | Sep 09, 2026, 06:15 PM UTC
M
Meta stock jumps to two-month high on TD Cowen Muse view
Meta Platforms (META) shares rose about 6% to a two-month high. TD Cowen flagged Meta Muse AI as a notable future revenue stream, while reports said Meta acquired a Swedish AI firm to bolster business AI agents.
EQUITY | Sep 09, 2026, 06:15 PM UTC
L
Merrill recruits three advisor practices totaling $1.7B in client assets
Merrill Lynch recruited three advisor practices from Morgan Stanley, Truist and Wells Fargo. The practices oversaw more than $1.7 billion in client assets at their former firms.
EQUITY | Sep 09, 2026, 06:15 PM UTC
L
Heating oil jumps 4.68% as energy commodity leaders firm
Heating Oil led gains up 4.68%, followed by Natural Gas EU up 4.14% and Natural Gas UK up 3.95%. Brent Oil rose 3.54% and Crude Oil rose 3.34%. Natural gas and gasoline were among the biggest losers.
COMMODITIES | Sep 09, 2026, 06:15 PM UTC
L
BKNG: Resilient travel demand, AI-driven efficiencies, and marketplace expansion fuel sustained growth
The company has transformed into a sophisticated travel marketplace, showing resilience amid global disruptions and driving growth through alternative accommodations, Connected Trip integration, and AI-powered efficienci
EQUITY | Sep 09, 2026, 06:14 PM UTC
L
West Pharma price target raised by UBS; rating kept at Buy
UBS maintained West Pharma at Buy and raised its price target to $415.00 per share from $340.00, according to TradingView News and Benzinga’s ratings action summary.
EQUITY | Sep 09, 2026, 06:13 PM UTC
L
TOL - Toll Brothers Announces Model Home Grand Opening at Wildspring in Leander, Texas
TOL - Toll Brothers Announces Model Home Grand Opening at Wildspring in Leander, Texas
EQUITY | Sep 09, 2026, 06:12 PM UTC
H
Investors buy 10-year Treasurys as auction clears at 4.834%
Investors bought $39 billion of 10-year Treasury notes in the auction. The auction yield was 4.834%, the highest level at any 10-year auction in 19 years, per Barrons.
EQUITY | Sep 09, 2026, 06:12 PM UTC
L
UBS maintains Buy on Veracyte; price target raised to $65
UBS maintains a Buy rating on Veracyte and raises its price target to $65.00 per share from $52.00, per Benzinga via TradingView News.
EQUITY | Sep 09, 2026, 06:11 PM UTC
M
Robinhood gets StoneX Buy and $170 target
StoneX Financial assigned a Buy rating and a $170 price target to Robinhood. Analyst Mark Palmer cited the broader business mix as a potential growth driver; Robinhood has 28.4 million funded customers.
EQUITY | Sep 09, 2026, 06:11 PM UTC
L
Inspire Brands names Dunkin’ head as interim CEO ahead of IPO
Inspire Brands named Dunkin’ unit head Scott Murphy as interim CEO ahead of its initial public offering, with CEO Paul Brown taking temporary medical leave, reported by WSJ.
EQUITY | Sep 09, 2026, 06:11 PM UTC
M
Microsoft slips as AI copyright litigation reaches summary-judgment phase
Microsoft (MSFT) entered the summary-judgment phase of consolidated copyright litigation brought by authors and news organizations. Shares slipped about 0.4% to $492.22 Wednesday morning.
EQUITY | Sep 09, 2026, 06:11 PM UTC
L
Alibaba ADR drops 2.6% amid new U.S. AI distillation threat allegations
Alibaba Group American depositary shares fell about 2.6% to $109.79 during Wednesday trading. The move followed fresh U.S. allegations over large-scale AI-model distillation.
GEOPOLITICS | Sep 09, 2026, 06:11 PM UTC
M
SK Hynix jumps nearly 5% as OpenAI boosts advanced-memory outlook
SK Hynix rose nearly 5% to $194.21 after OpenAI forecasts continued growth in advanced-memory requirements. OpenAI has signed letters of intent with SK Hynix and Samsung to supply memory for its Star…
EQUITY | Sep 09, 2026, 06:11 PM UTC
L
Robust 10-year Treasury auction eases yields after morning jump
A robust 10-year U.S. Treasury notes auction helped pare back an earlier surge in yields, bringing afternoon relief to the bond market after a morning Treasury announcement.
EQUITY | Sep 09, 2026, 06:11 PM UTC
H
FFIV guides revenue growth at 9%-10% amid AI and security demand
FFIV says hybrid multi-cloud, AI, and security trends are driving strong demand and portfolio expansion. Revenue growth is guided at 9%-10%, with software growth accelerating through FY 2027.
EARNINGS | Sep 09, 2026, 06:10 PM UTC
L
UBS raises UNFI price target to $50 from $47
UBS raised its United Natural Foods price target to $50.00 per share from $47.00, according to Benzinga ratings actions.
EQUITY | Sep 09, 2026, 06:10 PM UTC
L
Opus Genetics climbs to 52-week high after favorable study data
Shares of Opus Genetics reached a 52-week high after reporting favorable drug study data and a successful meeting with the FDA. Stock was recently up 26% to $5.46 and up about 171% this year.
REGULATION | Sep 09, 2026, 06:09 PM UTC
L
U.S. Treasury Sec. Bessent urges Senate to advance Clarity Act
U.S. Treasury Secretary Bessent urged the Senate to advance the Clarity Act on his return.
REGULATION | Sep 09, 2026, 06:09 PM UTC
M
STOK Phase III Dravet therapy reports durable 75%+ seizure reduction
Long-term data for a Phase III Dravet syndrome therapy show sustained 75%+ seizure reduction and functional gains. The pivotal EMPEROR trial is fully enrolled, with endpoints spanning seizures and cognitive improvements.
EQUITY | Sep 09, 2026, 06:08 PM UTC
L
UBS maintains neutral rating on 10x Genomics
UBS maintained a neutral rating on 10x Genomics, according to Benzinga ratings actions.
EQUITY | Sep 09, 2026, 06:08 PM UTC
L
Shoals Technologies growth outlook supported by BESS, data-center expansion
Expansion into BESS and data center markets is driving growth prospects for AirLink, with IP wins reinforcing market position and expected gross margin improvement as new products scale and facilities become more efficie
EARNINGS | Sep 09, 2026, 06:07 PM UTC
H
Houthis attack Saudi cities Khamis Mushait, Abha, Jazan with missiles, drones
Houthis attacked Saudi cities Khamis Mushait, Abha and Jazan on Wednesday with ballistic missiles and drones.
EQUITY | Sep 09, 2026, 06:07 PM UTC
L
UBS raises SLB price target to $72 from $66
UBS raised its SLB price target to $72.00 per share from $66.00.
EQUITY | Sep 09, 2026, 06:07 PM UTC
M
NBIX quarterly revenue hits $1 billion on Ingrezza, CRENESSITY strength
NBIX reported quarterly revenue of $1 billion, supported by growth in Ingrezza, CRENESSITY and VYKAT XR. The company cited outperforming Ingrezza and CRENESSITY expectations plus pipeline catalysts and commercial initiat
EQUITY | Sep 09, 2026, 06:07 PM UTC
H
Lululemon and Lowe’s slide after Wall Street cuts targets
Lululemon and Lowe’s came under pressure after Wall Street cut price targets, citing an uncertain Lululemon sales outlook and delayed recovery in Lowe’s home-improvement demand; LOW shares were down around 1% to a multi-
EARNINGS | Sep 09, 2026, 06:07 PM UTC
H
U.S. 10-year yield jumps as Treasury buyback plan disappoints
U.S. Treasury yields rose to new highs after investors were disappointed the expanded Treasury bond buyback program isn’t larger. The 10-year yield approached 4.85%, its highest since 2023.
EQUITY | Sep 09, 2026, 06:06 PM UTC
L
CRMD cites diversified specialty pharma platform and new market opportunities
CRMD says it has evolved into a diversified specialty pharma with eight marketed products and a scalable institutional platform, citing reimbursement transition, Medicare Advantage focus, REZZAYO expansion potential, and
EQUITY | Sep 09, 2026, 06:06 PM UTC
L
UBS raises Repligen price target to $225 from $195
UBS raised its Repligen price target to $225.00 per share from $195.00.
EQUITY | Sep 09, 2026, 06:06 PM UTC
H
XYZ raises 2026 profit guidance on AI and ecosystem momentum
XYZ raised 2026 guidance, citing profit and margin growth backed by broad-based gains across Square and Cash App. The company points to AI-driven product velocity, new distribution channels, and organizational agility, w
EARNINGS | Sep 09, 2026, 06:05 PM UTC
L
Raymond James raises Solaris Energy Infra price target to $96
Raymond James raised its Solaris Energy Infra price target to $96.00 per share from $82.00, per Benzinga ratings actions citing TradingView News.
EQUITY | Sep 09, 2026, 06:05 PM UTC
L
HSY: Innovation, disciplined investment, and portfolio expansion fuel confidence in multi-year growth
Profit restoration and innovation are driving strong performance, with top-line growth exceeding expectations and investments in R&D and brand building supporting future momentum. Salty snacks and international expansion
EQUITY | Sep 09, 2026, 06:05 PM UTC
L
NET: Agentic AI and new monetization strategies are set to drive accelerated, diversified growth
Significant growth is anticipated from agentic AI and new product cycles, with a shift to consumption-based revenue and expansion into media and content monetization. Strategic partnerships and ongoing innovation in netw
EQUITY | Sep 09, 2026, 06:05 PM UTC
M
SPTX outlines Glyph platform progress for oral neuropsychiatric therapies
SPTX presented its neuroscience pipeline, saying the Glyph platform can improve drug bioavailability and safety. Lead programs GlyphAllo and GlyphAgo target depression and anxiety, with promising clinical data and upcomi
EQUITY | Sep 09, 2026, 06:04 PM UTC
M
Tyra’s dabogratinib advances to phase III for MIBC
Dabogratinib, an oral FGFR3 inhibitor, reported phase II efficacy and safety in intermediate-risk MIBC, with 79% response and 64% CR rates at 60 mg. Phase III trials and UTUC expansion are planned.
EQUITY | Sep 09, 2026, 06:04 PM UTC
L
UBS raises Natera price target to $435
UBS raised Natera’s price target to $435.00 per share from $290.00 and maintained a Buy rating.
EQUITY | Sep 09, 2026, 06:04 PM UTC
L
Needham maintains BNED price target at $16.00 a share
Needham maintained its price target for BNED at $16.00 per share, according to ratings actions cited by Benzinga.
EQUITY | Sep 09, 2026, 06:04 PM UTC
L
OLED: OLED industry growth is accelerating with new IT capacity, foldable adoption, and key tech advances
New OLED capacity for IT and automotive is coming online, with foldable smartphones and IT displays expected to drive the next growth phase. Advances in phosphorescent blue and OLEDX technology support future efficiency
EQUITY | Sep 09, 2026, 06:04 PM UTC
L
KXS: AI-driven orchestration and strong SaaS growth position the company for scalable expansion
The company is expanding from supply chain planning into operational orchestration, leveraging AI and agentic architectures to bridge planning and execution. Strong growth in SaaS and ARR, high win rates, and a robust pa
EQUITY | Sep 09, 2026, 06:03 PM UTC
H
Brent crude crosses $100 on West Asia war supply fears
Brent crude crossed $100 a barrel for the first time in six weeks, rising as much as 2.8% to $100.70, amid escalating West Asia war concerns over tighter supplies that could widen India’s oil import bill.
COMMODITIES | Sep 09, 2026, 06:03 PM UTC
L
KARAM Safety secures Rs.600 crore investment from Motilal Oswal Alternates
KARAM Safety Private Limited said it has secured a Rs.600 crore investment from Motilal Oswal Alternates, citing a boost to expansion plans and international growth ambitions.
EQUITY | Sep 09, 2026, 06:03 PM UTC
L
Hyatt announces long-term strategic collaboration with Delta
Hyatt says it has announced a long-term strategic collaboration with Delta Air Lines to add benefits for members globally.
EQUITY | Sep 09, 2026, 06:03 PM UTC
L
US Treasury Debt Buyback
US Treasury Debt Buyback
RATES | Sep 09, 2026, 06:03 PM UTC
L
KSCP - Knightscope Puts the Three Ways to Buy Security Side by Side
KSCP - Knightscope Puts the Three Ways to Buy Security Side by Side
EQUITY | Sep 09, 2026, 06:03 PM UTC
L
BTIG maintains SailPoint price target at $21.00
BTIG maintained its $21.00/share price target for SailPoint.
EQUITY | Sep 09, 2026, 06:03 PM UTC
L
AstraZeneca shares fall about 1.3% after positive Phase 3 COPD results
AstraZeneca fell about 1.3% to $158 Wednesday, after its experimental COPD treatment reported positive Phase 3 results.
EQUITY | Sep 09, 2026, 06:02 PM UTC
L
Raymond James raises Braze price target to $33 from $27
Raymond James raised its price target on Braze to $33.00 per share from $27.00, while maintaining an Outperform rating, per TradingView News via Benzinga.
EQUITY | Sep 09, 2026, 06:02 PM UTC
L
MRVI maintained at neutral by UBS
UBS maintained Maravai LifeSciences at neutral on MRVI.
EQUITY | Sep 09, 2026, 06:02 PM UTC
H
Latest Escalation in US-Canada Trade Row Carries Sizable Indirect Cost — Market Talk
The direct cost to Canada from President Trump's latest tariff adjustment and import ban is a proverbial drop in the bucket, says economist Tu Nguyen of RSM Canada. "The indirect economic impact is more serious," she war
GEOPOLITICS | Sep 09, 2026, 06:01 PM UTC
L
FedEx launches Global Trade Navigator digital tools for international shipping
FedEx announced the launch of Global Trade Navigator, a suite bringing customs, duty, tax, documentation and clearance information earlier in the shipping process for businesses.
EQUITY | Sep 09, 2026, 06:01 PM UTC
L
SkyAI faces board challenge ahead of Sept. 18 meeting
Ahead of SkyAI’s Sept. 18 annual meeting, a shareholder group and would-be acquirer Forward Industries separately oppose the reelection of the entire board, as pressure mounts on the Solana treasury company.
CRYPTO | Sep 09, 2026, 06:01 PM UTC
L
Sandisk jumps after AI demand bets support NAND memory
Sandisk (SNDK) rose 2.4% to about $1,779.24 Wednesday, lifting market value toward $279 billion as investors bet on tight NAND supply amid AI-fueled memory demand.
EQUITY | Sep 09, 2026, 06:01 PM UTC
L
JPMorgan up about 0.5% as it expands corporate banking in Greece
JPMorgan Chase climbed about 0.5% to $355.01 Wednesday while pushing its corporate-banking franchise into Greece, offering lending, financing, hedging and investment-banking services to large and midsized Greek companies
EQUITY | Sep 09, 2026, 06:01 PM UTC
L
UBS raises Guardant Health price target to $225 from $175
UBS maintained Guardant Health at Buy and raised its price target to $225.00 per share from $175.00.
EQUITY | Sep 09, 2026, 06:00 PM UTC
L
Sanders convenes senators for AI briefing
Axios reports Sanders is convening senators for an AI briefing amid mounting alarm.
EQUITY | Sep 09, 2026, 06:00 PM UTC
M
DBV skin-based peanut allergy therapy reports 68% three-year tolerance
DBV said a skin-based therapy for pediatric peanut allergy showed strong safety and convenience, with 68% of young children tolerating peanuts after three years, and it is pursuing regulatory progress.
EQUITY | Sep 09, 2026, 06:00 PM UTC
L
HC Wainwright maintains Opus Genetics $8.00 share price target
HC Wainwright & Co. maintained its $8.00/share price target for Opus Genetics, according to Benzinga ratings actions.
EQUITY | Sep 09, 2026, 06:00 PM UTC
L
Raymond James cuts BridgeBio Oncology Thera price target to $22
Raymond James maintained a rating of Outperform on BridgeBio Oncology Thera and cut its price target to $22.00 from $24.00, according to Benzinga (TradingView News).
EQUITY | Sep 09, 2026, 06:00 PM UTC
L
Hunter Biden meme coin $LAPTOP collapses after debut
$LAPTOP dropped more than 95% from its peak of $199.51 to about $1.70 shortly after launching on Coinbase Global-affiliated blockchain Base, according to TradingView News.
CRYPTO | Sep 09, 2026, 06:00 PM UTC
L
Tradeweb sets Oct. 29, 2026 for Q3 2026 results release
Tradeweb Markets Inc. will report third-quarter 2026 financial results Thursday, October 29, 2026, at approximately 7:00 AM EDT, followed by an investor conference call and a live webcast.
EARNINGS | Sep 09, 2026, 06:00 PM UTC
L
Hyatt announces long-term strategic collaboration with Delta Air Lines
Hyatt announced a long-term strategic collaboration with Delta Air Lines to add benefits for members globally.
EQUITY | Sep 09, 2026, 06:00 PM UTC
L
Knightscope Puts the Three Ways to Buy Security Side by Side
Knightscope, Inc. (NASDAQ: KSCP), the security technology company building the nation’s first Autonomous Security Force, today published “Competitive Comparison,” the second field brief in its series, ahead of the Force’
EQUITY | Sep 09, 2026, 06:00 PM UTC
M
BEAM pipeline advances: pivotal trials progress in AATD and sickle cell
BEAM says pivotal trials are advancing for AATD and sickle cell, citing strong clinical data and regulatory alignment aimed at accelerated approval. The platform supports expansion into new indications and commercializat
EQUITY | Sep 09, 2026, 06:00 PM UTC
L
MRVL: AI-driven data center focus and innovation in networking and custom silicon fuel rapid, profitable growth
A decade-long pivot to data center and AI has driven explosive growth, with leadership in networking, optics, and custom silicon. The company is set for continued expansion, doubling custom sales next year and targeting
EQUITY | Sep 09, 2026, 05:59 PM UTC
L
D’Ieteren adjusted profit rises; guidance for low-to-mid single growth kept
D’Ieteren adjusted profit before tax group share rose 8.4% at constant FX. Belron, PHE and TVH delivered strong results, offsetting D’Ieteren Automotive’s decline. Full-year guidance for low to mid-single digit growth is
EARNINGS | Sep 09, 2026, 05:59 PM UTC
M
TRDA touts EEV platform safety and less frequent dosing for DMD
TRDA’s conference update said its EEV platform showed strong safety, enhanced delivery and less frequent dosing for DMD therapies, alongside early functional and biomarker data. It cited upcoming clinical readouts and ro
EQUITY | Sep 09, 2026, 05:59 PM UTC
L
FTC announces FY2027 telemarketer fees to access DNC registry
The Federal Trade Commission announced new telemarketer fees for access to the National Do Not Call Registry for Fiscal Year 2027, starting October 1, 2026.
REGULATION | Sep 09, 2026, 05:59 PM UTC
L
ATR: Execution, innovation, and early-stage pharma partnerships drive growth amid segment challenges
Leadership is focused on customer centricity, innovation, and execution, with North America beauty underperforming and pharma showing strong growth outside emergency medicine. Strategic investments in injectables and ear
EQUITY | Sep 09, 2026, 05:58 PM UTC
H
There's a Simple Fix for Social Security. Will Congress Get on Board? — Barrons.com
By Elizabeth O'BrienThere's no easy fix for Social Security, but a plan to raise top earners' taxes has recently gained traction with lawmakers and the public.The proposal isn't new, but it's gained fresh attention as So
GEOPOLITICS | Sep 09, 2026, 05:58 PM UTC
M
Jefferies Fund wins Singapore asset freeze case
Jefferies Fund won a Singapore asset freeze against Radiant World, per Bloomberg News.
EQUITY | Sep 09, 2026, 05:57 PM UTC
L
TDC highlights AI agent platforms and hybrid sovereign deployments
TDC says a conference spotlighted a shift to AI-driven, agent-enabled platforms, including an Autonomous Knowledge Platform and Tera Harness, to support hybrid, open and sovereign deployments.
EQUITY | Sep 09, 2026, 05:56 PM UTC
L
Digital Banks Seen as Needing More Growth to Disrupt Industry — Market Talk
Digital banks such as Revolut and Monzo have the opportunity to gain market share from traditional banks, Morgan Stanley says in a note. The banks have been quick to grow deposits and accounts, the analysts say. However,
EQUITY | Sep 09, 2026, 05:56 PM UTC
L
UBS raises Comstock Resources price target to $14 from $13
UBS raised its price target on Comstock Resources to $14.00 per share from $13.00, according to Benzinga ratings actions.
EQUITY | Sep 09, 2026, 05:56 PM UTC
L
Argent LNG and Albania sign MoU to evaluate LNG terminal
Argent LNG said it signed a non-binding memorandum of understanding with Albania’s government to evaluate an onshore LNG storage and regasification terminal with capacity up to 5 million tonnes a year.
EQUITY | Sep 09, 2026, 05:56 PM UTC
L
Apple announces foldable iPhone and iPhone Duo
Apple announced a foldable iPhone and an iPhone Duo.
EQUITY | Sep 09, 2026, 05:56 PM UTC
L
THC cites high-acuity ambulatory expansion driving revenue and margin growth
THC says expansion in high-acuity ambulatory procedures and hospital service lines is driving revenue and margin growth, supported by stable acquisition opportunities and increased capital investment, alongside technolog
MNA | Sep 09, 2026, 05:56 PM UTC
L
Roth Capital maintains $25 price target on BioAge Labs
Roth Capital maintained its price target of $25.00 per share for BioAge Labs, according to Benzinga’s ratings actions.
EQUITY | Sep 09, 2026, 05:56 PM UTC
L
UBS raises Chime Financial price target to $31 from $28
UBS maintained Chime Financial at Neutral and raised its price target to $31.00 per share from $28.00, per TradingView News citing Benzinga.
EQUITY | Sep 09, 2026, 05:55 PM UTC
M
IMUX nears pivotal Phase III readouts for vidofludimus calcium in relapsing MS
IMUX says vidofludimus calcium is nearing pivotal Phase III readouts in relapsing MS. The oral therapy targets both inflammatory and neurodegenerative mechanisms, aiming to address unmet needs in efficacy and safety.
EQUITY | Sep 09, 2026, 05:55 PM UTC
L
EYE shifts to unified vision care platform, targeting higher-value customers
EYE says leadership is transforming from a value-focused retailer to a unified vision care platform using technology, segmentation, and an employed doctor network.
EQUITY | Sep 09, 2026, 05:55 PM UTC
L
APPLE INTRODUCES IPHONE DUO
APPLE INTRODUCES IPHONE DUO
EQUITY | Sep 09, 2026, 05:55 PM UTC
L
BAX: Operational progress, margin expansion, and innovation drive growth amid ongoing portfolio optimization
Decentralization, continuous improvement, and debt reduction are driving operational and financial progress, with new leadership and product innovation supporting growth. Margin expansion and portfolio optimization remai
EQUITY | Sep 09, 2026, 05:55 PM UTC
L
Roth Capital sets Pasqal price target at $20.00/share
Roth Capital announced a $20.00 per-share price target for Pasqal Holding.
EQUITY | Sep 09, 2026, 05:55 PM UTC
L
Lukoil starts oil output at Komandirshorskoye field
Russia's Lukoil has started oil output at the Komandirshorskoye field.
COMMODITIES | Sep 09, 2026, 05:55 PM UTC
L
Lexicon plans SONATA-HCM phase III Q1 2027 data; T1D resubmission set
The summit said SONATA-HCM phase III data are expected in Q1 2027. It also cited FDA requirement meeting for SOTA in T1D and a planned T1D resubmission for Q4, alongside pipeline and partnership efforts.
REGULATION | Sep 09, 2026, 05:54 PM UTC
M
Apple announces foldable iPhone
Apple announced a foldable iPhone for AAPL.
EQUITY | Sep 09, 2026, 05:54 PM UTC
L
UBS raises Braze price target to $32 from $28
UBS raised Braze’s price target to $32.00 per share from $28.00.
EQUITY | Sep 09, 2026, 05:54 PM UTC
L
IG Group plans significant layoffs in reorganisation, Sky News reports
Britain’s IG Group LSE:IGG told staff that a significant number of jobs would be cut as part of a reorganisation aimed at improving efficiency, Sky News reported. IG declined to comment on the scale.
EQUITY | Sep 09, 2026, 05:54 PM UTC
L
APPLE ANNO9UNCE FOLDABLE DESIGN OF IPHONE
APPLE ANNO9UNCE FOLDABLE DESIGN OF IPHONE
EQUITY | Sep 09, 2026, 05:54 PM UTC
L
Gold edges higher as safe-haven demand offsets oil-led inflation worries
Gold prices inched higher on Wednesday, supported by safe-haven demand as investors assessed a surge in oil prices and related inflationary pressures.
COMMODITIES | Sep 09, 2026, 05:53 PM UTC
L
UBS raises Bruker price target to $65, maintains Neutral
UBS maintains a Neutral rating on Bruker and raises its price target to $65.00 per share from $45.00, according to Benzinga.
EQUITY | Sep 09, 2026, 05:53 PM UTC
L
NA: Profitable growth in Capital Markets, AI-driven efficiency, and Quebec-led mortgage expansion highlighted
Canadian economic prospects are positive due to reindustrialization and strong consumer fundamentals in Quebec, though U.S. trade tensions and inter-provincial barriers pose challenges. Strategic focus includes profitabl
EQUITY | Sep 09, 2026, 05:53 PM UTC
L
MSFT: Platform integration, AI model diversity, and efficiency drive growth and trusted enterprise adoption
The conference highlighted a strategy focused on platform completeness, AI model diversification, and efficiency gains to drive ROI and expand TAM. Pricing is shifting toward outcome-based models, while organizational ch
EQUITY | Sep 09, 2026, 05:52 PM UTC
H
Oil jumps above $100 as 10-year Treasury yield hits Nov 2023 high
Brent crude rose above $100 a barrel, reaching $100.27 in midday trading, up 2.4%. The 10-year Treasury yield hit its highest level since November 2023 as Middle East and inflation concerns weighed on Wall Street.
COMMODITIES | Sep 09, 2026, 05:52 PM UTC
L
KFY fee revenue rises 7% YoY as AMS boosts backlog, EBITDA outlook
KFY reported sixth straight quarter of growth with fee revenue up 7% year-over-year. The completed AMS acquisition lifted backlog to $3.5 billion and is expected to add $40 million incremental EBITDA within a year.
EARNINGS | Sep 09, 2026, 05:52 PM UTC
L
Apple Watch Series 12 starts at $399
Apple Watch Series 12 is priced from $399.
EQUITY | Sep 09, 2026, 05:52 PM UTC
H
BLZE: AI data explosion drives rapid growth, major AI deals, and strong financial momentum
AI-driven data growth is transforming storage into a critical innovation layer, with Backblaze leveraging its optimized platform and new managed storage offerings to win major AI infrastructure deals and expand rapidly.
EQUITY | Sep 09, 2026, 05:52 PM UTC
L
Apple Watch Series 12 starts at $399; Ultra 4 at $799
Apple Watch Series 12 pricing starts at $399. Apple Watch Ultra 4 is priced from $799.
EQUITY | Sep 09, 2026, 05:51 PM UTC
L
XENE’s Azetukalner nears U.S. launch for focal onset seizures
Azetukalner is advancing toward U.S. commercialization for focal onset seizures, with robust efficacy across four doses. Launch is set to target epileptologists and expand to general neurologists under a specialty pharma
EQUITY | Sep 09, 2026, 05:51 PM UTC
L
GILD: Diversified pipeline advances in HIV, oncology, and inflammation set up multiple launches and key data
The company is advancing a diversified pipeline across virology, oncology, and inflammation, with multiple new launches and promising clinical data expected in the next year. Key assets include long-acting HIV regimens,
EQUITY | Sep 09, 2026, 05:51 PM UTC
L
OMCL: Titan XT and OmniSphere drive innovation, margin focus, and market share gains in a robust refresh cycle
Management is driving a multi-year transformation with the Titan XT and OmniSphere platforms, focusing on innovation, customer experience, and flexible financing to capture market share. Margin expansion and disciplined
EQUITY | Sep 09, 2026, 05:51 PM UTC
L
PRESS RELEASE: Speech By ECB’s Nagel At The Gala Dinner Of The Deutsche Bundesbank On The Occasion Of The External ECB Governing Council Mee
READ HERE
CENTRAL_BANK | Sep 09, 2026, 05:51 PM UTC
L
CRGO founder urges shareholders to reset the board amid share struggle
CRGO founder Zvi Schreiber called on shareholders to shake up the board after saying he stayed silent for six months post-exit, citing the board’s “transition year” and “deliberately sequencing” growth.
EQUITY | Sep 09, 2026, 05:51 PM UTC
M
Sobi gets US FDA Fast Track for pacritinib in VEXAS
Sobi North America said the US FDA granted Fast Track designation to pacritinib for treatment of VEXAS syndrome.
REGULATION | Sep 09, 2026, 05:51 PM UTC
L
Jefferies Fund Reported To Have Won Singapore Asset Freeze Vs Radiant World
Jefferies Fund Reported To Have Won Singapore Asset Freeze Vs Radiant World
EQUITY | Sep 09, 2026, 05:49 PM UTC
L
EYE transformation to unified vision care platform flagged for growth
Leadership is transforming the value-focused optical retailer into an integrated vision care platform using technology, segmentation and an employed doctor model. Unified commerce and premiumization are expected to drive
EQUITY | Sep 09, 2026, 05:49 PM UTC
L
ZS expands AI security and zero-trust offerings on momentum
Year marked by significant platform expansion and rapid growth in AI security products, citing strong sales momentum and high customer satisfaction. Agentic SecOps launched, with Red Canary integration noted.
EQUITY | Sep 09, 2026, 05:48 PM UTC
M
Bitcoin miners trail as exchanges and stablecoins surge
Bitcoin posted one of its best weekly performances since 2020, climbing roughly 25% in late August to highs around $80K, while spot ETFs pull in capital, exchanges see heavy volume, and stablecoin dominance cracks.
CRYPTO | Sep 09, 2026, 05:48 PM UTC
L
CHH new leadership targets net rooms growth and AI efficiency
CHH’s new CEO is prioritizing net rooms growth, franchisee profitability, and capital recycling, with technology and AI investments aimed at improving operational efficiency and guest experience.
EQUITY | Sep 09, 2026, 05:46 PM UTC